This Million Shows Growing Confidence in 10x Genomics
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Consistency year to year matters for goals like retirement or college funding. This primer outlines how to assess return stability across periods.
24,555 articlesA hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
cdl’s $2.29 annual dividend remains resilient as Treasuries climb, offering a steady monthly cash flow through a uniq...
Microsoft stock pulled back early in 2026, turning headlines into a real question for investors: down 15%, should mic...
When a major IEEPA tariff ruling shifts policy, winners emerge in unexpected places, but the losers often reveal the ...
XRP has cooled off near $1.50 after a sharp drop. Before you buy the dip, learn what drives XRP's price, how Ripple's...
Amazon has faced headwinds and briefly dipped below $200. This guide explains how to evaluate a dip, set targets, and...
The 250th anniversary of The Wealth of Nations shines a spotlight on a potential shift away from pure free-market thi...
As the S&P 500 pushes higher, questions swirl about whether does michael burry know something the market isn’t pricin...
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
Investors watch every remark, but six underlying signals emerge from the words from chair kevin. This guide translate...
As markets shift in mid-2026, investors and borrowers weigh whether shelter costs or the stock market deliver stronge...
A year into UVXY's latest cycle, a $10,000 stake has fallen far beyond typical market moves. The fund's mechanics hav...